help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maier, J. A.
Right arrow Articles by Balsari, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maier, J. A.
Right arrow Articles by Balsari, A.

American Journal of Pathology, Vol 149, 945-952, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Tumor-necrosis-factor-induced fibroblast growth factor-1 acts as a survival factor in a transformed endothelial cell line

JA Maier, D Morelli, S Menard, MI Colnaghi and A Balsari
Department of Biomedical Sciences and Technologies, Ospedale San Raffaele, Milan, Italy.

Endothelial cells undergo apoptosis after withdrawal of growth factors, alterations in the extracellular matrix, or exposure to cytokines. Here we report that tumor necrosis factor (TNF)-alpha induces apoptosis of human endothelial cells derived from the umbilical vein in a dose- dependent fashion. Apoptosis is triggered through a pathway that is independent from the levels of Bcl-2. On the contrary, TNF stimulates the growth of spontaneously transformed human umbilical vein endothelial cells. This proliferative effect is mediated through the up- regulation of fibroblast growth factor-1 by TNF. The addition of specific fibroblast growth factor-1 antisense oligonucleotides inhibits TNF-induced fibroblast growth factor-1 expression, thus inhibiting the growth and triggering apoptosis of spontaneously transformed human umbilical vein endothelial cells.


This article has been cited by other articles:


Home page
J Hand Surg Eur VolHome page
R. M. D MEEK, S. McLELLAN, J REILLY, and J. F. CROSSAN
The Effect of Steroids on Dupuytren's Disease: Role of Programmed Cell Death
J Hand Surg Eur Vol., June 1, 2002; 27(3): 270 - 273.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
U. K. MESSMER, V. A. BRINER, and J. PFEILSCHIFTER
Basic Fibroblast Growth Factor Selectively Enhances TNF-{alpha}--Induced Apoptotic Cell Death in Glomerular Endothelial Cells: Effects on Apoptotic Signaling Pathways
J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2199 - 2211.
[Abstract] [Full Text]


Home page
IOVSHome page
M. E. Hartnett, C. M. Garcia, and P. A. D’Amore
Release of bFGF, an Endothelial Cell Survival Factor, by Osmotic Shock
Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2945 - 2951.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kinoshita and K. Shimokado
Autocrine FGF-2 Is Responsible for the Cell Density-Dependent Susceptibility to Apoptosis of HUVEC : A Role of a Calpain Inhibitor-Sensitive Mechanism
Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2323 - 2329.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
P. P. Molnar, B. P. O'Neill, B. W. Scheithauer, and D. R. Groothuis
The blood-brain barrier in primary CNS lymphomas: Ultrastructural evidence of endothelial cell death
Neuro-oncol, April 1, 1999; 1(2): 89 - 100.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.